Early Metformin Cuts Long COVID Risk

(MedPage Today) -- Early treatment with metformin reduced the risk of long COVID among outpatients, according to secondary results of a negative phase III trial. In the COVID-OUT study of over 1,100 randomized participants, the cumulative incidence...
Source: MedPage Today Public Health - Category: American Health Source Type: news